Race Oncology Limited (ASX:RAC)
Australia
· Delayed Price · Currency is AUD 2.870
+0.020 (0.70%)
At close: Dec 5, 2025
Race Oncology Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Other Revenue | 6.04 | 4.84 | 3.13 | 0.71 | 0.39 | Upgrade
|
| Revenue | 6.04 | 4.84 | 3.13 | 0.71 | 0.39 | Upgrade
|
| Revenue Growth (YoY) | 24.96% | 54.29% | 342.83% | 82.71% | 143.07% | Upgrade
|
| Cost of Revenue | 0.64 | 2.61 | 2.03 | 0.99 | 0.62 | Upgrade
|
| Gross Profit | 5.41 | 2.22 | 1.11 | -0.28 | -0.23 | Upgrade
|
| Selling, General & Admin | 3.28 | 3.79 | 3.04 | 4.33 | 3.34 | Upgrade
|
| Research & Development | 5.9 | 10.98 | 7.6 | 5.83 | 2.2 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| Other Operating Expenses | 0.66 | 0.82 | 0.66 | 0.48 | 0.31 | Upgrade
|
| Operating Expenses | 10.12 | 15.87 | 11.58 | 10.92 | 6.13 | Upgrade
|
| Operating Income | -4.72 | -13.65 | -10.48 | -11.2 | -6.36 | Upgrade
|
| Interest & Investment Income | - | - | 0.59 | 0.05 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.17 | -0.04 | -0.05 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -4.79 | -13.82 | -9.92 | -11.2 | -6.38 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.04 | Upgrade
|
| Pretax Income | -4.79 | -13.82 | -9.92 | -11.2 | -6.34 | Upgrade
|
| Net Income | -4.79 | -13.82 | -9.92 | -11.2 | -6.34 | Upgrade
|
| Net Income to Common | -4.79 | -13.82 | -9.92 | -11.2 | -6.34 | Upgrade
|
| Shares Outstanding (Basic) | 172 | 165 | 161 | 153 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 172 | 165 | 161 | 153 | 131 | Upgrade
|
| Shares Change (YoY) | 4.81% | 2.35% | 4.83% | 17.06% | 22.86% | Upgrade
|
| EPS (Basic) | -0.03 | -0.08 | -0.06 | -0.07 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.08 | -0.06 | -0.07 | -0.05 | Upgrade
|
| Gross Margin | 89.49% | 45.96% | 35.35% | -39.91% | -60.07% | Upgrade
|
| Operating Margin | -78.03% | -282.30% | -334.22% | -1582.76% | -1641.48% | Upgrade
|
| Profit Margin | -79.22% | -285.76% | -316.60% | -1582.63% | -1636.70% | Upgrade
|
| EBITDA | -4.43 | -13.37 | -10.19 | -10.92 | -6.08 | Upgrade
|
| EBITDA Margin | -73.37% | -276.48% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| EBIT | -4.72 | -13.65 | -10.48 | -11.2 | -6.36 | Upgrade
|
| EBIT Margin | -78.03% | -282.30% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.